DM005

News alerts, weekly reports and conference planners

Company:

Biocytogen, Doma Pharma

Drug class:

Topoisomerase I inhibitor, EGFR-targeted antibody-drug conjugate, c-MET-targeted antibody-drug conjugate

EGFR expression + MET expression	Pancreatic Ductal Adenocarcinoma	EGFR expression + MET expression	Pancreatic Ductal Adenocarcinoma	DM005 Sensitive: D – Preclinical DM005 Sensitive : D	DM005 Sensitive: D – Preclinical DM005 Sensitive : D
EGFR expression + MET expression	Non Small Cell Lung Cancer	EGFR expression + MET expression	Non Small Cell Lung Cancer	DM005 Sensitive: D – Preclinical DM005 Sensitive : D	DM005 Sensitive: D – Preclinical DM005 Sensitive : D

Associations
(2)